Pneumococcal polysaccharide vaccine: patient group direction template

PGD template to support the national pneumococcal polysaccharide vaccine (PPV) vaccination programme.


Pneumococcal polysaccharide vaccine (PPV): patient group direction (PGD) template

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email Please tell us what format you need. It will help us if you say what assistive technology you use.


This patient group direction (PGD) template supports the administration of 23-valent pneumococcal polysaccharide vaccine (PPV) to individuals from 65 years of age, and individuals from 2 years of age in a clinical risk group, in accordance with the national immunisation programme; and supports PPV administration to close contacts in accordance with UK guidelines for the public health management of clusters of serious pneumococcal disease in closed settings.

It is valid from 1 September 2018 to 31 August 2020.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement see Human Medicines Regulations 2012. Practitioners should follow local policy/procedures to access authorised PGD documents.

This PGD template should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.

Published 13 September 2016
Last updated 22 August 2018 + show all updates
  1. Added routine PGD update with indication for close contacts in a closed setting.
  2. First published.